The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Do antiepileptic drugs or generalized tonic–clonic seizure frequency increase SUDEP risk? A combined analysis
Abstract
Summary: Purpose: In an analysis of four case–control studies of sudden unexpected death in epilepsy (SUDEP), we found that yearly frequency of generalized tonic–clonic seizures (GTCS) and antiepileptic drug (AED) polytherapy were associated with an increased risk for SUDEP. The prior analysis, however, did not evaluate AEDs and GTCS frequency concurrently. Methods: We combined data from the three case–control studies with information on the frequency of GTCS and AED therapy, that is, carbamazepine, phenytoin, valproic acid, and other AED therapy. Number of AEDs was also considered. Lamotrigine and GTCS frequency were considered separately in two of the case–control studies. Logistic regression analysis was used to evaluate GTCS frequency, each of the AEDs, and number of AEDs. Adjusted analysis of the different AEDs accounted for study, age at death, gender, and GTCS frequency. Key Findings: In crude analysis, GTCS frequency, AED polytherapy, and number of AEDs were associated with an increased risk for SUDEP. Analysis of individual AEDs and of number of AEDs, adjusting for GTCS frequency, revealed no increased risk associated with AEDs as monotherapy, polytherapy, or total number. GTCS frequency remained strongly associated with an increased risk for SUDEP. Significance: Our findings—that none of the AEDs considered were associated with increased SUDEP risk as monotherapy or as polytherapy when GTCS frequency was taken into account—provide a consistent message that number of GTCS increases SUDEP risk and not AEDs. These results suggest that prevention of SUDEP must involve increased efforts to decrease GTCS frequency in order to avert the occurrence of this devastating epilepsy outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sudden unexpected death in epilepsy: current knowledge and future directions
Tomson, T., Nashef, L., & Ryvlin, P. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70202-3 · Cited by 673
Self-citationIncidence and risk factors in sudden unexpected death in epilepsy: A prospective cohort study
Walczak, T. S., Leppik, I. E., D’Amelio, M., Rarick, J., So, E., Ahman, P., Ruggles, K., Cascino, G. D., Annegers, J. F., & Hauser, W. A. (2001) · Neurology · doi:10.1212/wnl.56.4.519 · Cited by 545
Self-citationRisk factors for sudden unexpected death in epilepsy: a case control study
Nilsson, L., Farahmand, B., Persson, P.-G., Thiblin, I., & Tomson, T. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05114-9 · Cited by 522
Self-citationCombined analysis of risk factors for SUDEP: Combined SUDEP Analysis
Hesdorffer, D. C., Tomson, T., Benn, E., Sander, J. W., Nilsson, L., Langan, Y., Walczak, T. S., Beghi, E., Brodie, M. J., Hauser, A., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02952.x · Cited by 501
Self-citationLangan, Y., Nashef, L., & Sander, J. W. (2005) · Neurology · doi:10.1212/01.wnl.0000156352.61328.cb · Cited by 433
Self-citationSudden unexpected death in epilepsy: risk factors and potential pathomechanisms
Surges, R., Thijs, R. D., Tan, H. L., & Sander, J. W. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.118 · Cited by 431
Self-citationAn electroclinical case‐control study of sudden unexpected death in epilepsy
Lhatoo, S. D., Faulkner, H. J., Dembny, K., Trippick, K., Johnson, C., & Bird, J. M. (2010) · Annals of Neurology · doi:10.1002/ana.22101 · Cited by 361
Bateman, L. M., Spitz, M. C., & Seyal, M. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02513.x · Cited by 151
Lamotrigine in idiopathic epilepsy ? increased risk of cardiac death?
Aurlien, D., Taubøll, E., & Gjerstad, L. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00730.x · Cited by 78
Cited by
Moshé, S. L., Perucca, E., Ryvlin, P., & Tomson, T. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60456-6 · Cited by 905
Self-citationSudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention
Devinsky, O., Hesdorffer, D. C., Thurman, D. J., Lhatoo, S., & Richerson, G. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30158-2 · Cited by 721
Self-citationThe consequences of refractory epilepsy and its treatment
Laxer, K. D., Trinka, E., Hirsch, L. J., Cendes, F., Langfitt, J., Delanty, N., Resnick, T., & Benbadis, S. R. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.05.031 · Cited by 679
Harden, C., Tomson, T., Gloss, D., Buchhalter, J., Cross, J. H., Donner, E., French, J. A., Gil-Nagel, A., Hesdorffer, D. C., Smithson, W. H., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003685 · Cited by 578
Self-citationSudden unexpected death in epilepsy
Shorvon, S., & Tomson, T. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60176-1 · Cited by 501
Self-citation
Metadata
- Authors
- Hesdorffer, D. C., Tomson, T., Benn, E., Sander, J. W., Nilsson, L., Langan, Y., Walczak, T. S., Beghi, E., Brodie, M. J., Hauser, W. A., & for the ILAE Commission on Epidemiology; Subcommission on Mortality
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2011-12-22
- Volume
- 53
- Issue
- 2
- Pages
- 249-252
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W1513838333
- Cited by
- 261
- References
- 9
- FWCI
- 9.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Do antiepileptic drugs or generalized tonic–clonic seizure frequency increase SUDEP risk? A combined analysis. https://app.cochat.ai/papers/10.1111/j.1528-1167.2011.03354.x
- The paper
- Hesdorffer, D. C., Tomson, T., Benn, E., Sander, J. W., Nilsson, L., Langan, Y., Walczak, T. S., Beghi, E., Brodie, M. J., Hauser, W. A., & for the ILAE Commission on Epidemiology; Subcommission on Mortality. (2012). Do antiepileptic drugs or generalized tonic–clonic seizure frequency increase SUDEP risk? A combined analysis. Epilepsia. https://doi.org/10.1111/j.1528-1167.2011.03354.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.